Alireza Sadeghi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alireza Sadeghi has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Niloofar Dehdari Ebrahimi
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
9 shared publications - Erfan Taherifard
Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Yale School of Medicine, New Haven, CT, USA
6 shared publications - Ehsan Taherifard
Hematology Research Center Shiraz University of Medical Sciences Shiraz Iran
4 shared publications - Mohammad Amin Shahlaee
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
3 shared publications Niloofar Dehdari Ebrahimi
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
3 shared publications- Alireza Ahmadkhani
Department of Pathology Shiraz University of Medical Sciences Shiraz Iran
2 shared publications
Latest Publications
- Open Access
Bladder Cancer in the United States: National Trends and State-Level Patterns from Global Burden of Disease (GBD) Study, 1980-2021
Background: The U.S. has the highest health care expenditure globally. Examining long-term national and state-level trends, and benchmarking them against other health systems, can provide important insights for public health planning and policy development. Aim: This study aimed to characterize temporal trends in the burden of bladder cancer, including prevalence, incidence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs), and to evaluate state-level disparities and potential long-term effects of health policies. Methodology: Data were obtained from the Global Burden of Disease (GBD) 2021 study. Age- and sex-stratified trends were analyzed and visualized at both national and state levels across the study period. Burden estimates were additionally compared with those of other major health systems, including the European Union, countries with high socio-demographic index, and high-income settings. Results: In 2021, the U.S. recorded age-standardized rates of 8.35 for YLDs (0.33 lower), 3.41 for mortality (0.11 higher), 59.80 for YLLs (6.75 higher), 100.63 for prevalence (6.61 lower), 14.69 for incidence (0.51 lower), and 68.15 for DALYs (6.42 higher) compared to 1990 records. Lowest gender discrepancies across all measures were in 2021 were observed in District of Columbia with male:female ratio of DALYs: 2.4 [1.7, 3.2], mortality: 2.4 [1.8, 3.2], incidence: 2.5 [1.8, 3.4], prevalence: 2.4 [1.8, 3.2], YLDs: 2.4 [1.4, 4.1], and YLLs: 2.4 [1.7, 3.2]. In contrast, North and South Dakota had the highest gender discrepancies: DALYs: 3.9 [3.0, 5.2], incidence: 4.1 [3.1, 5.4], prevalence: 3.9 [3.0, 5.0], and YLLs: 4.0 [3.0, 5.2] and mortality: 4.2 [3.2, 5.6] and YLDs: 3.9 [2.3, 6.3]. Conclusion: Bladder cancer continues to impose a substantial and uneven burden across the U.S. State-level variations, driven by environmental factors, aging populations, and healthcare access gaps, require targeted prevention and improved early detection. Future research should assess the cost-effectiveness of prioritizing prevention over late-stage treatment to optimize healthcare spending.
Open AccessBladder Cancer in the United States: National Trends and State-Level Patterns from Global Burden of Disease (GBD) Study, 1980-2021
Background: The U.S. has the highest health care expenditure globally. Examining long-term national and state-level trends, and benchmarking them against other health systems, can provide important insights for public health planning and policy development. Aim: This study aimed to characterize temporal trends in the burden of bladder cancer, including prevalence, incidence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs), and to evaluate state-level disparities and potential long-term effects of health policies. Methodology: Data were obtained from the Global Burden of Disease (GBD) 2021 study. Age- and sex-stratified trends were analyzed and visualized at both national and state levels across the study period. Burden estimates were additionally compared with those of other major health systems, including the European Union, countries with high socio-demographic index, and high-income settings. Results: In 2021, the U.S. recorded age-standardized rates of 8.35 for YLDs (0.33 lower), 3.41 for mortality (0.11 higher), 59.80 for YLLs (6.75 higher), 100.63 for prevalence (6.61 lower), 14.69 for incidence (0.51 lower), and 68.15 for DALYs (6.42 higher) compared to 1990 records. Lowest gender discrepancies across all measures were in 2021 were observed in District of Columbia with male:female ratio of DALYs: 2.4 [1.7, 3.2], mortality: 2.4 [1.8, 3.2], incidence: 2.5 [1.8, 3.4], prevalence: 2.4 [1.8, 3.2], YLDs: 2.4 [1.4, 4.1], and YLLs: 2.4 [1.7, 3.2]. In contrast, North and South Dakota had the highest gender discrepancies: DALYs: 3.9 [3.0, 5.2], incidence: 4.1 [3.1, 5.4], prevalence: 3.9 [3.0, 5.0], and YLLs: 4.0 [3.0, 5.2] and mortality: 4.2 [3.2, 5.6] and YLDs: 3.9 [2.3, 6.3]. Conclusion: Bladder cancer continues to impose a substantial and uneven burden across the U.S. State-level variations, driven by environmental factors, aging populations, and healthcare access gaps, require targeted prevention and improved early detection. Future research should assess the cost-effectiveness of prioritizing prevention over late-stage treatment to optimize healthcare spending.
- Open Access
- 3 December 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (12) , e71604
Substance Use Among Iranian Youth: A Nationwide Cross‐Sectional Study on the Prevalence, Pattern, and Its Associated Factors
Background and Aims: Substance use poses a considerable challenge with adverse consequences on physical and psychological well‐being, and societal dynamics, particularly among adolescents and young adults. This cross‐sectional study aimed to investigate substance use prevalence and its associated factors among high school students across Iran. Methods: Eligible participants were high school students from all grades studying in the fields of Theoretical branches. An online questionnaire comprised of two sections was distributed to the target population utilizing a convenience sampling method; the first section of the questionnaire focused on demographic data, while the second gathered ever and recent substance use history. Multivariable Poisson regression was used to identify independent factors associated with the number of different substances used by the participants. Results: A total of 9402 individuals participated in this study, comprised of 56.9% males and 43.1% females. Of these, 3687 (39.2%) reported ever using at least one substance, and 2691 (28.6%) reported recent use. Among ever‐users, 53.0% used more than one substance type; among recent users, 47.1% used more than one type. A greater number of substances used (ever or recent) was associated with older age, being married, attendance at nonpublic schools, lower grade point average, single‐parent household, and lower parental education. Conclusion: A notable percentage of high school students had the experience of ever and recent substance use, underscoring the need for further preventive measures to address substance use among Iranian youth, with a focus on specific demographics.
- 3 December 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (12) , e71604
Open AccessSubstance Use Among Iranian Youth: A Nationwide Cross‐Sectional Study on the Prevalence, Pattern, and Its Associated Factors
Background and Aims: Substance use poses a considerable challenge with adverse consequences on physical and psychological well‐being, and societal dynamics, particularly among adolescents and young adults. This cross‐sectional study aimed to investigate substance use prevalence and its associated factors among high school students across Iran. Methods: Eligible participants were high school students from all grades studying in the fields of Theoretical branches. An online questionnaire comprised of two sections was distributed to the target population utilizing a convenience sampling method; the first section of the questionnaire focused on demographic data, while the second gathered ever and recent substance use history. Multivariable Poisson regression was used to identify independent factors associated with the number of different substances used by the participants. Results: A total of 9402 individuals participated in this study, comprised of 56.9% males and 43.1% females. Of these, 3687 (39.2%) reported ever using at least one substance, and 2691 (28.6%) reported recent use. Among ever‐users, 53.0% used more than one substance type; among recent users, 47.1% used more than one type. A greater number of substances used (ever or recent) was associated with older age, being married, attendance at nonpublic schools, lower grade point average, single‐parent household, and lower parental education. Conclusion: A notable percentage of high school students had the experience of ever and recent substance use, underscoring the need for further preventive measures to address substance use among Iranian youth, with a focus on specific demographics.
- Open Access
- 26 November 2025
- Published by Elsevier in Journal of Clinical and Translational Endocrinology: Case Reports
- Vol. 38
Triphala: A holistic remedy for male infertility - Insights from a case report in Persian traditional medicine
- 26 November 2025
- Published by Elsevier in Journal of Clinical and Translational Endocrinology: Case Reports
- Vol. 38
Open AccessTriphala: A holistic remedy for male infertility - Insights from a case report in Persian traditional medicine
- Top Cited PapersOpen Access
- 28 February 2025
- Published by Springer Nature in BMC Medicine
- Vol. 23 (1) , 1-19
Global and regional incidence of intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis
Background: Intrahepatic cholestasis of pregnancy (ICP) can be a source of significant distress for both pregnant women and the fetus, impairing the quality of life and well-being of pregnant women, leading to psychological disorders among pregnant women with severe or recurrent ICP, and causing life-threatening complications among fetuses. Regrettably, our current understanding of ICP globally is limited, lacking a comprehensive estimation of its incidence. Therefore, in this systematic review and meta-analysis, we aimed to investigate the global and regional incidence of ICP and identify factors that account for its variety across studies. Methods: A comprehensive search strategy was implemented across PubMed, Scopus, and Web of Science databases. To stabilize the variance, the Freeman-Tukey double arcsine transformation was employed. Subgroup analyses were conducted based on continent, publication type, study design and timing, regional classifications, developmental status, and World Bank income grouping. A multivariate meta-regression analysis was performed to estimate the effects of the continuous moderators on the effect size. Results: A total of 42,972,872 pregnant women were analyzed from 302 studies. The overall pooled incidence [95% confidence interval] of ICP was 2.9% [2.5, 3.3]. Studies with larger sample sizes tended to provide significantly lower estimates of ICP incidence: 1.6% [1.3, 2] vs 4.7% [3.9, 5.5]. Asia had the highest incidence of ICP among the continents, whereas Oceania had the lowest. Countries that were classified as developed and with higher income had a lower incidence of ICP than those classified as developing and low and middle income. Conclusions: The findings of this study will provide valuable insights into the current knowledge regarding the association of the quality of public health and socioeconomic variations with the incidence of ICP on a global scale. Graphical
- 28 February 2025
- Published by Springer Nature in BMC Medicine
- Vol. 23 (1) , 1-19
Top Cited PapersOpen AccessGlobal and regional incidence of intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis
Background: Intrahepatic cholestasis of pregnancy (ICP) can be a source of significant distress for both pregnant women and the fetus, impairing the quality of life and well-being of pregnant women, leading to psychological disorders among pregnant women with severe or recurrent ICP, and causing life-threatening complications among fetuses. Regrettably, our current understanding of ICP globally is limited, lacking a comprehensive estimation of its incidence. Therefore, in this systematic review and meta-analysis, we aimed to investigate the global and regional incidence of ICP and identify factors that account for its variety across studies. Methods: A comprehensive search strategy was implemented across PubMed, Scopus, and Web of Science databases. To stabilize the variance, the Freeman-Tukey double arcsine transformation was employed. Subgroup analyses were conducted based on continent, publication type, study design and timing, regional classifications, developmental status, and World Bank income grouping. A multivariate meta-regression analysis was performed to estimate the effects of the continuous moderators on the effect size. Results: A total of 42,972,872 pregnant women were analyzed from 302 studies. The overall pooled incidence [95% confidence interval] of ICP was 2.9% [2.5, 3.3]. Studies with larger sample sizes tended to provide significantly lower estimates of ICP incidence: 1.6% [1.3, 2] vs 4.7% [3.9, 5.5]. Asia had the highest incidence of ICP among the continents, whereas Oceania had the lowest. Countries that were classified as developed and with higher income had a lower incidence of ICP than those classified as developing and low and middle income. Conclusions: The findings of this study will provide valuable insights into the current knowledge regarding the association of the quality of public health and socioeconomic variations with the incidence of ICP on a global scale. Graphical
- Open Access
- 19 February 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (2) , e70431
Evaluation of the Effects of Postsleeve Gastrectomy Exercise on Long‐Term Glucose Profile and Weight Loss Among Iranian Females: A Prospective Cohort Study From 2016 to 2020
Background: Weight regain after surgery is linked to an increased risk of relapse for obesity‐related comorbidities, such as type 2 diabetes mellitus (T2DM). This study aims to explore how exercise after laparoscopic sleeve gastrectomy (LSG) affects glucose levels and the percentage of excess body weight loss (%EBWL).Methods: In this study, females with non‐insulin‐dependent T2DM who underwent LSG between 2014 and 2015 were enrolled and followed at 1 and 4 years postoperatively in a prospective cohort design. Data on glucose profile, body mass index, and the quality and quantity of exercise were collected. Adequate activity was defined as engaging in more than 150 min of exercise per week. Participants were divided into two groups: the control cohort (low activity) and the exposure cohort (adequate activity). The primary outcomes were %EBWL and glycated hemoglobin (HbA1c). Statistical analysis was performed using paired t‐tests and linear regression in the R programming language.Results: The study comprised 246 female participants with a mean age of 46.93 ± 8.07 years, drawn from an initial cohort of 249 individuals. Significant associations were observed between %EBWL, fasting blood glucose, and HbA1c with the intensity of exercise. The active cohort exhibited superior outcomes in terms of %EBWL (78.1 ± 22.06 vs. 28.1 ± 10.9), reductions in HbA1c (−0.37% vs. −0.01%), and a decrease in body mass index (−11.6 vs. −8.46 kg/m²). The following formula was established to predict %EBWL at 48 months based on exercise levels (R2 = 0.86): %EBWL (at 48‐month) = −5 (if no exercise at all) + 1*exercise time (minutes/day) + 10*exercise frequency (session/week).Conclusion: This study highlights the essential role of postoperative exercise in facilitating long‐term weight loss and modest improvements in glucose profiles. The developed formula effectively predicts %EBWL based on the patient's exercise profile, thereby emphasizing the significance of physical activity and patient engagement in attaining sustained positive outcomes. It is recommended that patients receive guidance on maintaining an active exercise regimen.
- 19 February 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (2) , e70431
Open AccessEvaluation of the Effects of Postsleeve Gastrectomy Exercise on Long‐Term Glucose Profile and Weight Loss Among Iranian Females: A Prospective Cohort Study From 2016 to 2020
Background: Weight regain after surgery is linked to an increased risk of relapse for obesity‐related comorbidities, such as type 2 diabetes mellitus (T2DM). This study aims to explore how exercise after laparoscopic sleeve gastrectomy (LSG) affects glucose levels and the percentage of excess body weight loss (%EBWL).Methods: In this study, females with non‐insulin‐dependent T2DM who underwent LSG between 2014 and 2015 were enrolled and followed at 1 and 4 years postoperatively in a prospective cohort design. Data on glucose profile, body mass index, and the quality and quantity of exercise were collected. Adequate activity was defined as engaging in more than 150 min of exercise per week. Participants were divided into two groups: the control cohort (low activity) and the exposure cohort (adequate activity). The primary outcomes were %EBWL and glycated hemoglobin (HbA1c). Statistical analysis was performed using paired t‐tests and linear regression in the R programming language.Results: The study comprised 246 female participants with a mean age of 46.93 ± 8.07 years, drawn from an initial cohort of 249 individuals. Significant associations were observed between %EBWL, fasting blood glucose, and HbA1c with the intensity of exercise. The active cohort exhibited superior outcomes in terms of %EBWL (78.1 ± 22.06 vs. 28.1 ± 10.9), reductions in HbA1c (−0.37% vs. −0.01%), and a decrease in body mass index (−11.6 vs. −8.46 kg/m²). The following formula was established to predict %EBWL at 48 months based on exercise levels (R2 = 0.86): %EBWL (at 48‐month) = −5 (if no exercise at all) + 1*exercise time (minutes/day) + 10*exercise frequency (session/week).Conclusion: This study highlights the essential role of postoperative exercise in facilitating long‐term weight loss and modest improvements in glucose profiles. The developed formula effectively predicts %EBWL based on the patient's exercise profile, thereby emphasizing the significance of physical activity and patient engagement in attaining sustained positive outcomes. It is recommended that patients receive guidance on maintaining an active exercise regimen.
- Open Access
- 16 October 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (12) , 7062-7071
Radio-protective effects of melatonin therapy against testicular oxidative stress: a systematic review and meta-analysis of rodent models
Background: Radiation exposure is a concern in today’s world, given the widespread use of electronic devices and medical procedures involving ionizing and non-ionizing radiation. Radiations may cause male infertility by inducing oxidative stress in testicular tissue. Melatonin has antioxidant properties. Methods: We systematically reviewed the literature for the studies that have investigated the effects of melatonin therapy on radiation-induced oxidative stress in rodents’ testicular tissue. PubMed, Scopus, and Web of Science were searched for relevant animal trials. Standardized mean difference and 95% confidence intervals were used to pool the data. Subgroup and sensitivity analyses were done. The risk of bias was assessed using SYRCLE tool. Results: Outcomes: histopathology and sperm analyses (testicular apoptotic cells, Johnsen’s testicular biopsy score, seminiferous epithelial height, tubular diameter, sperm motility, viability, count, and morphology, concentration of spermatid, spermatocyte, and spermatogonia), body and testes weights (absolute and relative body and testicular weights), reproductive hormones (serum prolactin, FSH, and testosterone), and oxidative stress tissue markers (TBARS, CAT, GSH, GSH-Px, MDA, SOD, and XO, and total antioxidant capacity). Rats and mice were exposed to electromagnetic radiations (gamma, roentgen, microwave, radiofrequency, and high-power line energy) and particle waves (radioiodine and carbon-ion). Melatonin therapy was significantly associated with improved male reproduction. Conclusion: Radiation exposure harms male fertility, but melatonin, as an antioxidant, is potentially associated with improved male reproductive function in rodents. Inconsistencies in research require further investigations. Export
- 16 October 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (12) , 7062-7071
Open AccessRadio-protective effects of melatonin therapy against testicular oxidative stress: a systematic review and meta-analysis of rodent models
Background: Radiation exposure is a concern in today’s world, given the widespread use of electronic devices and medical procedures involving ionizing and non-ionizing radiation. Radiations may cause male infertility by inducing oxidative stress in testicular tissue. Melatonin has antioxidant properties. Methods: We systematically reviewed the literature for the studies that have investigated the effects of melatonin therapy on radiation-induced oxidative stress in rodents’ testicular tissue. PubMed, Scopus, and Web of Science were searched for relevant animal trials. Standardized mean difference and 95% confidence intervals were used to pool the data. Subgroup and sensitivity analyses were done. The risk of bias was assessed using SYRCLE tool. Results: Outcomes: histopathology and sperm analyses (testicular apoptotic cells, Johnsen’s testicular biopsy score, seminiferous epithelial height, tubular diameter, sperm motility, viability, count, and morphology, concentration of spermatid, spermatocyte, and spermatogonia), body and testes weights (absolute and relative body and testicular weights), reproductive hormones (serum prolactin, FSH, and testosterone), and oxidative stress tissue markers (TBARS, CAT, GSH, GSH-Px, MDA, SOD, and XO, and total antioxidant capacity). Rats and mice were exposed to electromagnetic radiations (gamma, roentgen, microwave, radiofrequency, and high-power line energy) and particle waves (radioiodine and carbon-ion). Melatonin therapy was significantly associated with improved male reproduction. Conclusion: Radiation exposure harms male fertility, but melatonin, as an antioxidant, is potentially associated with improved male reproductive function in rodents. Inconsistencies in research require further investigations. Export
- Open Access
- 23 June 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (6) , e2212
Electrocardiographic findings in patients with sickle cell disease: A protocol for systematic review and meta‐analysis
Background: Despite advancements in the management of patients with sickle cell disease (SCD), the involvement of the cardiovascular system in these patients remains a significant concern. Cardiovascular manifestations of SCD are well‐documented, with electrocardiography (ECG) serving as a valuable diagnostic tool. Studies have reported a high rate of critical ECG findings in patients with SCD that warrants consideration when managing these patients, indicating the need for proactive cardiac screening and management strategies in this patient population. This study aims to systematically review the literature to identify sociodemographic, clinical, and paraclinical factors associated with ECG abnormalities in patients with SCD.Methods: A comprehensive search strategy will be employed across multiple online databases, including PubMed, Embase, Scopus, Web of Science, and Google Scholar, for published and gray literature. Eligible studies will include original articles reporting associations between sociodemographic, clinical, and paraclinical variables and a spectrum of ECG findings in patients with SCD. Independent reviewers will conduct the screening, quality assessment, and data extraction. Quantitative analyses will be performed under a random‐effect model using Comprehensive Meta‐Analysis software, with subgroup analyses based on SCD status, sickle hemoglobinopathy form, and age group.
- 23 June 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (6) , e2212
Open AccessElectrocardiographic findings in patients with sickle cell disease: A protocol for systematic review and meta‐analysis
Background: Despite advancements in the management of patients with sickle cell disease (SCD), the involvement of the cardiovascular system in these patients remains a significant concern. Cardiovascular manifestations of SCD are well‐documented, with electrocardiography (ECG) serving as a valuable diagnostic tool. Studies have reported a high rate of critical ECG findings in patients with SCD that warrants consideration when managing these patients, indicating the need for proactive cardiac screening and management strategies in this patient population. This study aims to systematically review the literature to identify sociodemographic, clinical, and paraclinical factors associated with ECG abnormalities in patients with SCD.Methods: A comprehensive search strategy will be employed across multiple online databases, including PubMed, Embase, Scopus, Web of Science, and Google Scholar, for published and gray literature. Eligible studies will include original articles reporting associations between sociodemographic, clinical, and paraclinical variables and a spectrum of ECG findings in patients with SCD. Independent reviewers will conduct the screening, quality assessment, and data extraction. Quantitative analyses will be performed under a random‐effect model using Comprehensive Meta‐Analysis software, with subgroup analyses based on SCD status, sickle hemoglobinopathy form, and age group.
- 10 April 2024
- Published by Springer Nature in Infection
- Vol. 52 (4) , 1223-1234
Estimates of global and regional prevalence of Helicobacter pylori infection among individuals with obesity: a systematic review and meta-analysis
Purpose The prevalence of obesity is an escalating concern in modern populations, predominantly attributed to the widespread adoption of sedentary lifestyles observed globally. Extensive research has established a significant association between obesity and Helicobacter pylori (H. pylori). Nonetheless, a comprehensive assessment of the global prevalence of H. pylori among individuals with obesity remains undetermined. Methods A systematic search strategy was applied to PubMed, Scopus, and Web of Science. The resulting records were screened using the Rayyan online tool for the management of systematic reviews. Freeman–Tukey double arcsine transformation was used. Subgroup analyses (continent, regional classifications, developmental status, religion, global hemisphere, income, access to international waters, and H. pylori eradication) and multivariate meta-regression (latitude, longitude, male-to-all ratio, mean age, and body mass index) were done to estimate the effects of the moderators. Risk of bias assessment was done using JBI checklist for prevalence studies. Results A total of 472,511 individuals with obesity from 208 studies were included. The global estimation of H. pylori prevalence among individuals with obesity was 32.3% (95% CI 26.9%, 38.0%). South America had the highest prevalence. Based on the different classifications of countries, resource-rich, low-/middle-income, developing, and Islamic countries had the highest prevalence. Lower pooled prevalence was observed in the studies with adequate sample sizes (n ≥ 270). Conclusion The findings have the potential to influence future health policies for preventing and treating H. pylori infection. However, there is variability among the included studies, indicating the need for more population-based research.
- 10 April 2024
- Published by Springer Nature in Infection
- Vol. 52 (4) , 1223-1234
Estimates of global and regional prevalence of Helicobacter pylori infection among individuals with obesity: a systematic review and meta-analysis
Purpose The prevalence of obesity is an escalating concern in modern populations, predominantly attributed to the widespread adoption of sedentary lifestyles observed globally. Extensive research has established a significant association between obesity and Helicobacter pylori (H. pylori). Nonetheless, a comprehensive assessment of the global prevalence of H. pylori among individuals with obesity remains undetermined. Methods A systematic search strategy was applied to PubMed, Scopus, and Web of Science. The resulting records were screened using the Rayyan online tool for the management of systematic reviews. Freeman–Tukey double arcsine transformation was used. Subgroup analyses (continent, regional classifications, developmental status, religion, global hemisphere, income, access to international waters, and H. pylori eradication) and multivariate meta-regression (latitude, longitude, male-to-all ratio, mean age, and body mass index) were done to estimate the effects of the moderators. Risk of bias assessment was done using JBI checklist for prevalence studies. Results A total of 472,511 individuals with obesity from 208 studies were included. The global estimation of H. pylori prevalence among individuals with obesity was 32.3% (95% CI 26.9%, 38.0%). South America had the highest prevalence. Based on the different classifications of countries, resource-rich, low-/middle-income, developing, and Islamic countries had the highest prevalence. Lower pooled prevalence was observed in the studies with adequate sample sizes (n ≥ 270). Conclusion The findings have the potential to influence future health policies for preventing and treating H. pylori infection. However, there is variability among the included studies, indicating the need for more population-based research.
- Open Access
- 15 February 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (2) , e1901
Global incidence of intrahepatic cholestasis of pregnancy: A protocol for systematic review and meta‐analysis
Background: Intrahepatic cholestasis of pregnancy (ICP) typically develops in the late second and third trimesters and resolves rapidly after delivery. Although not associated with serious maternal sequelae, ICP can be highly bothersome. On the other hand, the major complications of ICP are fetal and neonatal, which can be fatal. The current knowledge lacks an estimation regarding the global prevalence of ICP. Methods: PubMed, Scopus, and Web of Science will be searched systematically. Records will be screened for eligibility by two independent reviewers. Observational studies that reported the incidence of ICP will be eligible. Joanna Bridge Institute checklist for appraisal of prevalence studies will be used for quality assessment. Freeman‐Tukey double arcsine transformed effect sizes will be pooled under random‐effect models. The residual between study heterogeneity will be quantified using I 2 statistic. Further investigations will be done using subgroup and meta‐regression analyses. Discussion: Estimating the global and regional prevalence of ICP and evaluating the effects of moderating factors will provide valuable insights into the knowledge. Further investigations on the moderating factors will help researchers to hypothesize the associations and extend the current understanding of the disease. The planned study will be the first systematic review and meta‐analysis that estimates the global prevalence of ICP. The reviewers will try rigorous mythology to ensure high‐quality evidence. However, substantial heterogeneity is expected as prevalence studies utilize different mythologies, settings, and definitions. Moreover, this study relies on utilizing previously published studies, which may impede the overall data quality and comprehensiveness.
- 15 February 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (2) , e1901
Open AccessGlobal incidence of intrahepatic cholestasis of pregnancy: A protocol for systematic review and meta‐analysis
Background: Intrahepatic cholestasis of pregnancy (ICP) typically develops in the late second and third trimesters and resolves rapidly after delivery. Although not associated with serious maternal sequelae, ICP can be highly bothersome. On the other hand, the major complications of ICP are fetal and neonatal, which can be fatal. The current knowledge lacks an estimation regarding the global prevalence of ICP. Methods: PubMed, Scopus, and Web of Science will be searched systematically. Records will be screened for eligibility by two independent reviewers. Observational studies that reported the incidence of ICP will be eligible. Joanna Bridge Institute checklist for appraisal of prevalence studies will be used for quality assessment. Freeman‐Tukey double arcsine transformed effect sizes will be pooled under random‐effect models. The residual between study heterogeneity will be quantified using I 2 statistic. Further investigations will be done using subgroup and meta‐regression analyses. Discussion: Estimating the global and regional prevalence of ICP and evaluating the effects of moderating factors will provide valuable insights into the knowledge. Further investigations on the moderating factors will help researchers to hypothesize the associations and extend the current understanding of the disease. The planned study will be the first systematic review and meta‐analysis that estimates the global prevalence of ICP. The reviewers will try rigorous mythology to ensure high‐quality evidence. However, substantial heterogeneity is expected as prevalence studies utilize different mythologies, settings, and definitions. Moreover, this study relies on utilizing previously published studies, which may impede the overall data quality and comprehensiveness.
- 13 February 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (5) , e30916
Electrocardiographic abnormalities in patients with sickle cell disease: A systematic review and meta‐analysis
Background: Previous studies have documented that electrocardiography (ECG) can reveal a range of abnormalities, offering valuable insights into the cardiac evaluation of patients with sickle cell disease (SCD). The objective of this study is to assess the patterns of ECG abnormalities observed in these patients with SCD, and to determine their prevalence.Method: We systematically reviewed the literature using online databases of PubMed, Scopus, Web of Science, Embase, and Google Scholar to identify original studies that reported findings of standard ECG assessments in patients with SCD. Statistical analyses were performed using the random effects model. Additional analyses including sensitivity analysis and subgroup analysis were also conducted.Results: Analysis of data from 59 studies involving 897,920 individuals with SCD revealed that 75% of these patients had abnormal ECG findings (67%–81%), which were predominantly nonspecific ST–T changes, left ventricular hypertrophy, T‐wave changes, prolonged corrected QT (QTc) interval, and ischemic changes. Besides, it was shown that these patients had significantly higher odds of having any ECG abnormalities (OR of 17.50, 4.68–65.49), right atrial enlargement (6.09, 1.48–25.09), left ventricular hypertrophy (3.45, 1.73–6.89), right ventricular hypertrophy (7.18, 2.28–22.57), biventricular hypertrophy (10.11, 1.99–51.38), prolonged QTc interval (5.54, 2.44–12.59), ST depression (3.34, 1.87–5.97), and T‐wave changes (5.41, 1.43–20.56). Moreover, the mean of QTc interval was significantly higher among those with SCD (23.51 milliseconds, 16.08–30.94).Conclusion: Our meta‐analysis showed a higher prevalence of abnormal ECG findings among individuals with SCD. A significant proportion of these patients had various ECG abnormalities, suggesting a potential need for regular ECG assessments for patients with SCD.
- 13 February 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (5) , e30916
Electrocardiographic abnormalities in patients with sickle cell disease: A systematic review and meta‐analysis
Background: Previous studies have documented that electrocardiography (ECG) can reveal a range of abnormalities, offering valuable insights into the cardiac evaluation of patients with sickle cell disease (SCD). The objective of this study is to assess the patterns of ECG abnormalities observed in these patients with SCD, and to determine their prevalence.Method: We systematically reviewed the literature using online databases of PubMed, Scopus, Web of Science, Embase, and Google Scholar to identify original studies that reported findings of standard ECG assessments in patients with SCD. Statistical analyses were performed using the random effects model. Additional analyses including sensitivity analysis and subgroup analysis were also conducted.Results: Analysis of data from 59 studies involving 897,920 individuals with SCD revealed that 75% of these patients had abnormal ECG findings (67%–81%), which were predominantly nonspecific ST–T changes, left ventricular hypertrophy, T‐wave changes, prolonged corrected QT (QTc) interval, and ischemic changes. Besides, it was shown that these patients had significantly higher odds of having any ECG abnormalities (OR of 17.50, 4.68–65.49), right atrial enlargement (6.09, 1.48–25.09), left ventricular hypertrophy (3.45, 1.73–6.89), right ventricular hypertrophy (7.18, 2.28–22.57), biventricular hypertrophy (10.11, 1.99–51.38), prolonged QTc interval (5.54, 2.44–12.59), ST depression (3.34, 1.87–5.97), and T‐wave changes (5.41, 1.43–20.56). Moreover, the mean of QTc interval was significantly higher among those with SCD (23.51 milliseconds, 16.08–30.94).Conclusion: Our meta‐analysis showed a higher prevalence of abnormal ECG findings among individuals with SCD. A significant proportion of these patients had various ECG abnormalities, suggesting a potential need for regular ECG assessments for patients with SCD.